Home Tags Daniel Fabricant

Tag: Daniel Fabricant

NPA Alerts DHS, HHS & DOJ to Concerns with Dietary Supplement Listing Act of...

Washington, D.C.—On April 26, 2022, Senators Richard Durbin (D-IL) and Mike Braun (R-IN) introduced the Dietary Supplement Listing Act of 2022 with the intent of...

Remembering Senator Orrin G. Hatch, Dietary Supplement Industry Champion

Senator Orrin G. Hatch (R-Utah), who served in the Senate for seven terms before retiring in 2018, passed away on Saturday, April 23, at...

FDA Issuing Enforcement Discretion Guidance on NAC

Washington, D.C.—The U.S. Food and Drug Administration (FDA) announced in a Constituent Update that it is issuing  “Policy Regarding N-acetyl-L-cysteine: Draft Guidance for Industry”...

Industry Reacts to FDA FY 2023 Budget Request; Proposal to Modernize Dietary Supplement Regulation

The U.S. Food and Drug Administration (FDA) announced that its request for a total budget of $8.4 billion as part of the President’s fiscal...

NPA’s Fabricant to Discuss Supplement Restriction Bill on CBS

Washington, D.C.—Daniel Fabricant, Ph.D., President and CEO of the Natural Products Association (NPA), will appear on the CBS show “The Doctors” on February 7,...

NPA Sounds Alarm: CA Set to Restrict Access to Weight Loss Supplements

Washington, D.C.—UPDATED 1/27/22: The Natural Products Association (NPA) shared that the California Assembly passed AB-1341: Dietary supplements for weight loss and over-the-counter diet pills...

NPA: Intellectual Property Protection Key to Consumer Safety & Innovation for Natural Products Industry

Washington, D.C.—Stressing the importance of intellectual property protection for both consumer safety and product innovation, the Natural Products Association (NPA) has filed comments with...

NPA Files Citizen Petition with FDA over NAC

Washington, D.C.—The Natural Products Association (NPA) has filed a Citizen’s Petition with the Food and Drug Administration, requesting that N-acetyl-L-cysteine (NAC) not be excluded...

Draft Legislation Aims to Decriminalize Cannabis, Set Safe Level of CBD Consumption

Washington, D.C.—Senate Majority Leader Chuck Schumer (D-NY), Senate Finance Committee Chair Ron Wyden (D-OR), and Senator Cory Booker (D-NJ) have released a discussion draft...

SSCI Announces First Company to Meet Its Benchmarking Standards

Washington, D.C.—The Supplement Safety & Compliance Initiative (SSCI) announced the first company to meet its new safety and benchmarking standards: Natural Alternatives International (NAI)....